26 results
8-K
EX-1.1
EPIX
Essa Pharma Inc
6 Nov 23
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement
4:57pm
or will comply in all material respects with the requirements of Rule 433 under the Securities Act including timely filing with the Commission or retention
8-K
EX-3.1
EPIX
Essa Pharma Inc
15 Sep 23
Amendments to Articles of Incorporation or Bylaws
7:56pm
for Poll Not to Prevent Continuance of Meeting
Retention of Ballots and Proxies
ARTICLE 12 VOTES OF SHAREHOLDERS
Number of Votes by Shareholder … a poll has been demanded.
Retention of Ballots and Proxies
The Company must, for at least three months after a meeting of shareholders, keep at its
8-K
EX-1.1
rr0 vvlf9iuij
22 Feb 21
Other Events
5:16pm
DEF 14A
fspso
26 Jan 21
Definitive proxy
4:49pm
PRE 14A
u40 2shjtb8o
19 Jan 21
Preliminary proxy
12:00am
10-K
3l3fw3rh
15 Dec 20
Annual report
5:02pm
6-K
EX-99.1
9drvhk4jybej39vh tnj
6 Aug 20
Current report (foreign)
12:19pm
6-K
EX-99.1
kddvj
14 Apr 20
Open Market Sale Agreementsm
12:00am
6-K
EX-99.2
kdum20
24 May 19
Material Change Report
8:42pm
6-K
EX-99.1
4b1d lfamm4k7xzrp95
19 Feb 19
Statement of Executive Compensation
4:07pm
F-3
EX-4.1
dkeo16ws6s
28 Jun 18
Shelf registration (foreign)
5:22pm
6-K
EX-99.4
ub4xbl26
25 May 18
Current report (foreign)
12:00am